News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for
Fluocinolone Implant Slows Retinopathy in Macular Edema
Source: Medscape Diabetes & Endocrinology Headlines [2017.01.19]
Researchers say fluocinolone implants can delay proliferative diabetic retinopathy and slow progression of diabetic retinopathy in patients with diabetic macular edema.
Medscape Medical News
Macular degeneration: Study sheds light on Alzheimer's proteins in retina
Source: Eye Health / Blindness News From Medical News Today [2016.11.23]
Study reveals new insights into the molecular mechanisms of beta-amyloid buildup - a hallmark of Alzheimer's disease - in the retina of people with AMD.
Source: MedicineNet Eyeglasses, Sunglasses, and Magnifiers Specialty [2016.05.06]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 12:00:00 AM
Last Editorial Review: 5/6/2016 12:00:00 AM
Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010
Alzheimer's disease proteins could be at fault for leading cause of vision loss among older people
Source: Eye Health / Blindness News From Medical News Today [2016.11.22]
Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older.
Microbes in your gut influence major eye disease
Source: Eye Health / Blindness News From Medical News Today [2016.11.17]
Bacteria in your intestines may play an important role in determining if you will develop blinding wet Age-related Macular Degeneration (AMD).
Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.